+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiff Oncology - logo
Acquired Gene or Chromosome Alterations Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update - Product Thumbnail Image

Acquired Gene or Chromosome Alterations Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • Report
  • December 2023
  • 283 Pages
  • Global
From
Serine/Threonine Protein Kinase PLK1 - Pipeline Review, H2 2020 - Product Thumbnail Image

Serine/Threonine Protein Kinase PLK1 - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 111 Pages
  • Global
From
Ovarian Cancer - Pipeline Review, H1 2020 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 3802 Pages
  • Global
From
Cardiff Oncology Inc (CRDF:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Cardiff Oncology Inc (CRDF:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • January 2024
  • 89 Pages
From
Comprehensive Report on Cardiff Oncology Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Cardiff Oncology Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Cardiff Oncology Inc (CRDF) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Cardiff Oncology Inc (CRDF) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • June 2023
  • 53 Pages
From
Loading Indicator